Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colitis, Ulcerative 2Lymphoma 1Inflammatory Bowel Diseases 1Crohn Disease 1Arthritis, Rheumatoid 1

Interventions

golimumab 2Infliximab 2Papillomavirus Vaccines 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1CT-P13 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Colitis, Ulcerative × golimumab × Clear all
NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT02186886 2014-07-10

Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab

Kliniken im Naturpark Altmuehltal

Phase 4 Unknown
50 enrolled

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡